Provided by Tiger Trade Technology Pte. Ltd.

Mirum Pharmaceuticals, Inc.

88.51
-2.2100-2.44%
Post-market: 88.510.00000.00%19:16 EDT
Volume:2.23M
Turnover:197.92M
Market Cap:5.34B
PE:-188.32
High:91.70
Open:90.73
Low:86.90
Close:90.72
52wk High:109.28
52wk Low:36.88
Shares:60.34M
Float Shares:39.99M
Volume Ratio:2.62
T/O Rate:5.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4700
EPS(LYR):-0.4700
ROE:-8.65%
ROA:-1.83%
PB:16.97
PE(LYR):-188.32

Loading ...

Oct 17, 2023

Major Issues Report

Form 8-K - Current report
Oct 14, 2023

Major Issues Report

Form 8-K - Current report
Sep 19, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 12, 2023

Major Issues Report

Form 8-K - Current report
Sep 06, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Sep 06, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 05, 2023

Major Issues Report

Form 8-K - Current report
Aug 30, 2023

Major Issues Report

Form 8-K - Current report
Aug 07, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 03, 2023

Major Issues Report

Form 8-K - Current report
Jul 17, 2023

Major Issues Report

Form 8-K - Current report
Jun 24, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 14, 2023

Major Issues Report

Form 8-K - Current report
Jun 08, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 04, 2023

Major Issues Report

8-K - Current report
May 04, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 03, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 03, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Apr 17, 2023

Major Issues Report

8-K - Current report